
News|Podcasts|March 28, 2025
From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer
Author(s)Alexandra Gerlach, Content Producer
Colorectal cancer cases are on the rise—here is everything you need to know as an oncology pharmacist.
Advertisement
Colorectal cancer (CRC) is the third most common cancer around the world, and although it primarily affects older individuals, diagnoses are on the rise in younger adults. In this episode, we explore the factors driving this increase, the evolving treatment landscape, and the role of emerging therapies in patient care. Our guest, Megan May, PharmD, BCOP, FHOPA, FAPO, clinical oncology pharmacy specialist at Baptist Health, shares insights on the factors driving increased diagnoses, navigating CRC treatment, and the critical role of pharmacists in supporting patient care.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Breakthrough Therapy Designation to Investigational Cannabis-Derived Therapy for Chronic Low Back Pain
2
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
3
ADA 2026: Subcutaneous Furosemide May Reduce Heart Failure Hospitalizations in Patients With Diabetes
4
First-Ever Guideline on Cardio-Kidney-Metabolic Syndrome Calls for Earlier Screening, Coordinated Care
5





































































































































